FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2070219923> ?p ?o ?g. }

• W2070219923 endingPage "450" @default.
• W2070219923 startingPage "441" @default.
• W2070219923 abstract "We conducted a matched-cohort analysis of autologous transplant conditioning regimens for diffuse large cell lymphoma in 92 patients treated with either radioimmunotherapy (RIT) or total body irradiation (TBI)–based conditioning regimens. The RIT regimen consisted of 0.4 mCi/kg of 90Y-ibritumomab tiuxetan plus BEAM (BCNU, etoposide, cytarabine, melphalan). The TBI-based regimen combined fractionated TBI at 1200 cGy, with etoposide and cyclophosphamide. Five factors were matched between 46 patient pairs: age at transplant ±5 years, disease status at salvage, number of prior regimens, year of diagnosis ±5 years, and year of transplantation ±5 years. Patients in the TBI group had higher rates of cardiac toxicity and mucositis, whereas Z-BEAM patients had a higher incidence of pulmonary toxicity. Overall survival at 4 years was 81.0% for the Z-BEAM and 52.7% for the TBI group (P = .01). The 4-year cumulative incidence of relapse/progression was 40.4% and 42.1% for Z-BEAM and TBI, respectively (P = .63). Nonrelapse mortality was superior in the Z-BEAM group: 0% compared with 15.8% for TBI at 4 years (P < .01). Our data demonstrate that RIT-based conditioning had a similar relapse incidence to TBI, with lower toxicity, resulting in improved overall survival, particularly in patients with ≥2 prior regimens. We conducted a matched-cohort analysis of autologous transplant conditioning regimens for diffuse large cell lymphoma in 92 patients treated with either radioimmunotherapy (RIT) or total body irradiation (TBI)–based conditioning regimens. The RIT regimen consisted of 0.4 mCi/kg of 90Y-ibritumomab tiuxetan plus BEAM (BCNU, etoposide, cytarabine, melphalan). The TBI-based regimen combined fractionated TBI at 1200 cGy, with etoposide and cyclophosphamide. Five factors were matched between 46 patient pairs: age at transplant ±5 years, disease status at salvage, number of prior regimens, year of diagnosis ±5 years, and year of transplantation ±5 years. Patients in the TBI group had higher rates of cardiac toxicity and mucositis, whereas Z-BEAM patients had a higher incidence of pulmonary toxicity. Overall survival at 4 years was 81.0% for the Z-BEAM and 52.7% for the TBI group (P = .01). The 4-year cumulative incidence of relapse/progression was 40.4% and 42.1% for Z-BEAM and TBI, respectively (P = .63). Nonrelapse mortality was superior in the Z-BEAM group: 0% compared with 15.8% for TBI at 4 years (P < .01). Our data demonstrate that RIT-based conditioning had a similar relapse incidence to TBI, with lower toxicity, resulting in improved overall survival, particularly in patients with ≥2 prior regimens." @default.
• W2070219923 created "2016-06-24" @default.
• W2070219923 creator A5004910687 @default.
• W2070219923 creator A5026632776 @default.
• W2070219923 creator A5035985145 @default.
• W2070219923 creator A5039374832 @default.
• W2070219923 creator A5052032114 @default.
• W2070219923 creator A5072320451 @default.
• W2070219923 creator A5083138054 @default.
• W2070219923 creator A5091213586 @default.
• W2070219923 date "2012-03-01" @default.
• W2070219923 modified "2023-10-01" @default.
• W2070219923 title "Matched-Cohort Analysis of Autologous Hematopoietic Cell Transplantation with Radioimmunotherapy versus Total Body Irradiation–Based Conditioning for Poor-Risk Diffuse Large Cell Lymphoma" @default.
• W2070219923 cites W1497143314 @default.
• W2070219923 cites W1544519462 @default.
• W2070219923 cites W1819949687 @default.
• W2070219923 cites W1912693401 @default.
• W2070219923 cites W1973617793 @default.
• W2070219923 cites W1995118081 @default.
• W2070219923 cites W1997353354 @default.
• W2070219923 cites W2038981426 @default.
• W2070219923 cites W2043799126 @default.
• W2070219923 cites W2045209749 @default.
• W2070219923 cites W2048483756 @default.
• W2070219923 cites W2058015212 @default.
• W2070219923 cites W2073140442 @default.
• W2070219923 cites W2110646221 @default.
• W2070219923 cites W2114465730 @default.
• W2070219923 cites W2134642572 @default.
• W2070219923 cites W2143776006 @default.
• W2070219923 cites W2149156161 @default.
• W2070219923 cites W2150587745 @default.
• W2070219923 cites W2167571754 @default.
• W2070219923 cites W2253580546 @default.
• W2070219923 cites W2257242967 @default.
• W2070219923 cites W2331817699 @default.
• W2070219923 cites W4205736005 @default.
• W2070219923 cites W4232605254 @default.
• W2070219923 doi "https://doi.org/10.1016/j.bbmt.2011.07.016" @default.
• W2070219923 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3433244" @default.
• W2070219923 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21801706" @default.
• W2070219923 hasPublicationYear "2012" @default.
• W2070219923 type Work @default.
• W2070219923 sameAs 2070219923 @default.
• W2070219923 citedByCount "34" @default.
• W2070219923 countsByYear W20702199232012 @default.
• W2070219923 countsByYear W20702199232013 @default.
• W2070219923 countsByYear W20702199232014 @default.
• W2070219923 countsByYear W20702199232015 @default.
• W2070219923 countsByYear W20702199232016 @default.
• W2070219923 countsByYear W20702199232017 @default.
• W2070219923 countsByYear W20702199232018 @default.
• W2070219923 countsByYear W20702199232022 @default.
• W2070219923 countsByYear W20702199232023 @default.
• W2070219923 crossrefType "journal-article" @default.
• W2070219923 hasAuthorship W2070219923A5004910687 @default.
• W2070219923 hasAuthorship W2070219923A5026632776 @default.
• W2070219923 hasAuthorship W2070219923A5035985145 @default.
• W2070219923 hasAuthorship W2070219923A5039374832 @default.
• W2070219923 hasAuthorship W2070219923A5052032114 @default.
• W2070219923 hasAuthorship W2070219923A5072320451 @default.
• W2070219923 hasAuthorship W2070219923A5083138054 @default.
• W2070219923 hasAuthorship W2070219923A5091213586 @default.
• W2070219923 hasBestOaLocation W20702199231 @default.
• W2070219923 hasConcept C126322002 @default.
• W2070219923 hasConcept C141071460 @default.
• W2070219923 hasConcept C143998085 @default.
• W2070219923 hasConcept C159654299 @default.
• W2070219923 hasConcept C203014093 @default.
• W2070219923 hasConcept C2776146153 @default.
• W2070219923 hasConcept C2776694085 @default.
• W2070219923 hasConcept C2776755627 @default.
• W2070219923 hasConcept C2778119113 @default.
• W2070219923 hasConcept C2778496288 @default.
• W2070219923 hasConcept C2778515704 @default.
• W2070219923 hasConcept C2778559949 @default.
• W2070219923 hasConcept C2778880498 @default.
• W2070219923 hasConcept C2779338263 @default.
• W2070219923 hasConcept C2781413609 @default.
• W2070219923 hasConcept C2911091166 @default.
• W2070219923 hasConcept C509974204 @default.
• W2070219923 hasConcept C542903549 @default.
• W2070219923 hasConcept C71924100 @default.
• W2070219923 hasConcept C88879693 @default.
• W2070219923 hasConceptScore W2070219923C126322002 @default.
• W2070219923 hasConceptScore W2070219923C141071460 @default.
• W2070219923 hasConceptScore W2070219923C143998085 @default.
• W2070219923 hasConceptScore W2070219923C159654299 @default.
• W2070219923 hasConceptScore W2070219923C203014093 @default.
• W2070219923 hasConceptScore W2070219923C2776146153 @default.
• W2070219923 hasConceptScore W2070219923C2776694085 @default.
• W2070219923 hasConceptScore W2070219923C2776755627 @default.
• W2070219923 hasConceptScore W2070219923C2778119113 @default.
• W2070219923 hasConceptScore W2070219923C2778496288 @default.
• W2070219923 hasConceptScore W2070219923C2778515704 @default.
• W2070219923 hasConceptScore W2070219923C2778559949 @default.
• W2070219923 hasConceptScore W2070219923C2778880498 @default.
• W2070219923 hasConceptScore W2070219923C2779338263 @default.

• next